Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis by Winden, C.M. van et al.
Eur Respir J 1998; 12: 143–147
DOI: 10.1183/09031936.98.12010143
Printed in UK - all rights reserved
Copyright ©ERS Journals Ltd 1998
European Respiratory Journal
ISSN 0903 - 1936
Effects of flutter and PEP mask physiotherapy on symptoms and 
lung function in children with cystic fibrosis
C.M.Q. van Winden*+, A. Visser**, W. Hop‡, P.J. Sterk+, S. Beckers*, J.C. de Jongste*
Cystic fibrosis (CF) patients have viscous bronchial
secretions, endobronchial infection and, hence, destruction
of the lung and deterioration of lung function [1]. Sput-
um expectoration, aided by chest physiotherapy (CPT),
postural drainage, percussion and coughing, have been
standard therapy for many years [1, 2]. Self-administered
physiotherapy techniques, including the forced expiration
technique (FET), active cycle of breathing technique
(ACBT), autogenic drainage and the use of a positive expi-
ratory pressure (PEP) mask provide personal independence
for the patient and have largely replaced earlier techniques
[3–11]. It is uncertain whether any of these newer meth-
ods, or combinations of different techniques, are better
than others [1, 11–14].
A new device to facilitate clearance of mucus is the
flutter. When the patient exhales through the flutter, oscil-
lations of expiratory pressure and airflow vibrate the air-
way walls, should diminish adhesiveness of mucus,
decrease the collapsibility of the airways and accelerate
airflow [15]. The use of the flutter may therefore result in
expectoration of a greater amount of sputum than the use
of postural drainage or coughing in CF patients [15]. Also,
improvement in lung function after 14 days of physiother-
apy with the use of the flutter was reported in adult
patients with chronic obstructive bronchitis [16] and pre-
liminary data suggest the same for patients with CF [17,
18]. In contrast, most studies with the PEP mask failed to
show short-term benefit or improvement in lung function
or symptoms [5, 19, 20] or were inconclusive because
other aspects of the treatment may have been responsible
for an observed effect [21]. It seems, therefore, that the
flutter might have advantages over the more commonly
used PEP mask. This study aimed to compare the effects
of the flutter and the PEP mask in children with CF.
Materials and methods
Patients
Twenty-two patients, 12 males and 10 females, with
CF confirmed by sweat test and/or deoxyribonucleic acid
(DNA) mutation analysis, with a mean age of 12 yrs
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ABSTRACT: Recently, the flutter was introduced as a new device to improve sputum
expectoration. Preliminary data suggested a significant improvement in expectora-
tion and lung function during flutter treatment in patients with cystic fibrosis (CF).
The aim of the present study was to compare the effects of the flutter and the positive
expiratory pressure (PEP) mask on symptoms and lung function in children with CF.
In a crossover randomized study 22 patients with CF (mean age 12 yrs, range 7–17
yrs) performed physiotherapy using either the flutter or the PEP mask twice a day
during two treatment periods of 2 weeks, separated by a one week wash-out period, in
a random sequence. Lung function parameters (peak expiratory flow, forced vital
capacity (FVC), forced expiratory volume in one second, maximal midexpiratory
flow, maximal expiratory flow at 25% of FVC, thoracic gas volume, total lung capac-
ity, residual volume/total lung capacity, airway resistance and specific airway con-
ductance) and changes in transcutaneous oxygen haemoglobin saturation were
assessed before and after the first supervised session and at the end of each treatment
period. Throughout the study peak flow was measured and symptoms were scored
daily.
No significant changes in any lung function parameter occurred after a single ses-
sion or after 2 weeks of physiotherapy with either method. There was no difference in
acceptability and subjective efficacy.
In conclusion, any superiority of the flutter over the positive expiratory pressure
mask technique for expectoration could not be confirmed during 2 weeks of daily
treatment in children with cystic fibrosis. Both methods are well accepted by children
and do not change lung function. Long-term comparison of both methods, including
expectoration measurements, seems to be required for further evaluation of the
potential success of physiotherapy in cystic fibrosis.
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(range 7–17 yrs) participated in the study. Characteristics
of these subjects are given in table 1. All patients were
clinically stable for at least 2 weeks prior to the study, as
shown by stable peak flows and symptom scores by ques-
tionnaire, could perform lung function tests reproducibly
(within-subject range of three successive forced expira-
tory volume in one second (FEV1) manoeuvres <10%)
and had productive cough on most days. All participants
gave written informed consent.
Study design
The study has a crossover design (fig. 1). Patients con-
tinued to receive their usual medication throughout the
study (excluded: mucolytics other than saline) in unchang-
ed doses and they continued FET. Peak flow was measured
daily after the morning physiotherapy session by means
of a Mini-Wright peak-flow meter (Clement Clarke, Lon-
don, UK) and a questionnaire on symptoms of daytime
and night-time cough, sputum production and shortness of
breath (each being scored on a three-point scale) was
completed daily. The cumulative number of symptoms in
a given period was taken as the symptom score.
Each patient was assigned randomly to one of two treat-
ment sequences. After a one-week run-in period (first
wash-out), either the PEP mask or the flutter was intro-
duced and continued for 2 weeks, twice a day. After a sec-
ond wash-out period of 1 week, both groups changed to
the alternative treatment by flutter or PEP mask for
another 2 weeks. During the two wash-out periods, all
patients performed routine physiotherapy with FET, pre-
ceded by nebulization of 10 mL of 0.9% NaCl, but with-
out the PEP mask or the flutter. At the end of each
treatment period the patients and their parents completed
a questionnaire regarding the acceptability and perceived
efficacy of each physiotherapy method. At the end of the
study the patients were asked for their preference. The
study was approved by the Medical Ethics Committee of
the hospital and was performed according to the directives
of Good Clinical Practice.
Physiotherapy regimens
Ten millilitres of 0.9% NaCl was nebulized via an ultra-
sonic nebulizer (Medasonic; Medasto, Woerden, The Neth-
erlands) before each physiotherapy session. All patients
were familiar with the use of the PEP mask and had used
this at home for an average of 4.0 yrs (range 0.5–8 yrs)
before the study. All patients were instructed how to use
the flutter and the PEP mask on two occasions preceding
each treatment period. After each treatment period the
technique was checked by observing and scoring various
aspects of the entire procedure. A paediatric physiothera-
pist experienced in CF treatment (A.Visser) supervised
the instruction and the use of the PEP mask and the flutter.
Both techniques were combined with FET to clear the
central airways. The number of huff and cough manoeu-
vres was standardized, because it has been shown that
huffing and coughing as individual techniques are effec-
tive as well [12, 23, 24].
Positive expiratory pressure mask
The PEP-mask (Astra Meditec, Rijswijk, The Nether-
lands) was used as follows. Sitting with a straight back
and the elbows supported on the table, the patient pressed
the mask against the face with both hands. After a quiet
inhalation, a slow active exhalation followed. The exha-
lation was restricted by a resistance selected to cause a
positive expiratory pressure of 8–12 cmH2O. The patient
exhaled 15 times through the mask. Thereafter, the patient
huffed three times and evacuated sputum by a voluntary
cough. This sequence was repeated five times [25, 26].
Flutter
The flutter (VarioRaw, Aubonne, Switzerland) was
used as follows. Sitting with a straight back and the
elbows supported on the table, the patient held the flutter
horizontally. The patient inhaled deeply, held their breath
for 2 or 3 s and then took the mouthpiece into the mouth
and exhaled quietly yet quickly enough to activate the
flutter. The patient had to keep their cheeks as stiff as pos-
sible. This procedure was repeated 15 times, following
which the patient huffed three times and evacuated sputum
by a voluntary cough. This sequence was repeated five
times. The patient obtained the maximal vibration sensa-
tion by tilting the flutter upwards or downwards by a few
degrees.
Table 1.  –  Baseline characteristics of cystic fibrosis
patients
Total group
n=22
PEP first
n=10
Flutter first
n=12
Female  n
Age  yrs*
FEV1*+
FVC*+
Inhaled β-agonists
Inhaled corticosteroids
Inhaled antibiotics
Oral antibiotics, daily
Oral corticosteroids
Pseudomonas coloniza-
   tion
10
12 (7–17)
82 (55–129)
95 (77–133)
15
7
1
14
3
14
6
13 (8–16)
79 (63–120)
90 (77–126)
7
4
1
7
2
7
4
11 (7–17)
86 (55–129)
99 (79–133)
8
3
0
7
1
7
*: median (range). +: lung function on study entry, expressed in
percentage predicted values [22]. PEP: positive expiratory pres-
sure; FEV1: forced expiratory volume in one second; FVC:
forced vital capacity.
Wash-out Wash-out
PEP mask
FlutterPEP mask
Flutter
Lung function
Duration 1 week 2 weeks 1 week 2 weeks
Fig. 1.  –  Study design. PEP: positive expiratory pressure.
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Lung function
On the first day of the run-in period, flow-volume
curves were performed to establish baseline values of dy-
namic lung volumes and flows. Lung function was also
measured on the first day of each of the two treatment
periods before and 30 min after the first supervised ses-
sion of physiotherapy. At the end of 14-day treatment
period, lung function parameters were measured 30 min
after physiotherapy. Prior to lung function tests, the pati-
ents discontinued any inhalation therapy except saline for
8 h. Peak expiratory flow (PEF), forced vital capacity
(FVC), FEV1, maximal expiratory flow at 50% of FVC
(MMEF) and maximal expiratory flow at 25% of FVC
(MEF25) were measured by means of a calibrated pneu-
motachograph (Masterlab, Jaeger, Würzburg, Germany).
The best of three forced expiration measurements was
taken. Total lung capacity (TLC), residual volume (RV/
TLC), airway resistance (Raw) and specific airway cond-
uctance (sGaw) were measured by means of whole body
plethysmography (Masterlab, Jaeger). The results were ex-
pressed as a percentage of predicted values [22]. After the
first session of physiotherapy and after 2 weeks of treat-
ment the effect of a bronchodilator (terbutaline 1 mg via a
Turbuhaler) was measured by repeating the flow-volume
curve 30 min after treatment. The percentage of transcuta-
neous haemoglobin oxygen saturation (Stc,O2) was meas-
ured by pulse oximetry (Ohmeda Biox, Louisville CO,
USA) before, during and 30 min after all supervised ses-
sions.
Statistical analysis
The results of the lung function tests before and after
the first session of physiotherapy following the wash-out
periods and changes in lung function parameters before
and after 2 weeks of the two different physiotherapy
methods were compared by means of paired t-tests. The
appropriateness of this test was verified by securing that
there were no carry-over or period effects using methods
which are suitable for crossover studies [27]. In view of
the number of parameters compared, statistical signifi-
cance was assumed at p=0.01 (two-sided). With n=22, the
power to detect differences of roughly 1 SD at p=0.01 is at
least 80%. Data given are means±SEM unless indicated oth-
erwise.
Results
All 22 patients completed the study. Twelve patients
started to use the flutter and 10 started to use the PEP
mask in the first treatment period. At the onset of the
study the mean results of flow-volume measurements,
peak flow values and symptom scores were similar
between both groups and did not change significantly dur-
ing the run-in period. The lung function parameters meas-
ured before physiotherapy on the first day of each two-
week treatment period were also similar (table 2). The
mean symptom score was 10±1 during the first and 10±2
during the second wash-out period. The mean PEF was
309±15 L·min-1 during the first and 319±20 L·min-1 during
the second wash-out period (nonsignificant difference, NS).
These figures were similar for each of the two sequence
groups. During the PEP periods the mean peak flow was
similar to that during the flutter periods (316 L·min-1 and
319 L·min-1, respectively, NS). Slightly more symptoms
were recorded during the PEP periods than during the
flutter periods, not due to a specific symptom category
(average symptom scores 23 and 19, respectively, NS). The
results of the lung function tests are shown in table 2.
There were no significant changes in mean values of any
of the lung function parameters after one session or after 2
weeks of physiotherapy with both methods. The effect of
inhaled terbutaline after 2 weeks of physiotherapy with
either method was unchanged from the effect on the first
day.
It was postulated that those patients preferring one of
the devices could have shown more improvement with
that device than with the other. Therefore, data were ana-
lysed separately with the patients grouped according to
their preference. However, those who preferred the PEP
mask were similar to those preferring the flutter in all
respects.
The mean Stc,O2 before the sessions with the PEP mask
was 96±0.2% (range 94–99%). No significant differences
were found between the two treatments before, directly
after and 30 min after physiotherapy. During and immedi-
ately after the physiotherapy sessions desaturation (arterial
oxygen saturation (Sa,O2) <92%) occurred in one patient
using the PEP mask and in six patients using the flutter.
This lasted for <2 min in all but one patient.
Evaluation of the correct use of the PEP mask and the
flutter after each treatment period showed good compli-
ance and good technique of performance, with the excep-
tion of breath holding with the use of the flutter: 21 of 22
patients held their breath after inhalation for <3 s.
Subjective improvement, preference, time needed and
effect on sputum production were similar for both treat-
ments. Ten patients preferred the PEP mask, 11 patients
preferred the flutter and one patient had no preference.
Table 2.  –  Baseline characteristics of cystic fibrosis
patients
Flutter PEP mask
Before After After 2 
weeks Before After
After 2 
weeks
FVC
FEV1
∆FEV1*
∆FEV1/FVC*
TGV
TLC
RV/TLC
PEF
MEF25
MMEF25–75
Raw
99±4
87±5
120±5
106±3
139±7
92±3
41±5
55±5
237±22
99±4
86±5
+5±1
+3±1
119±4
107±2
140±7
90±3
38±4
57±6
239±22
99±4
88±4
+5±1
+2±1
122±4
105±3
138±8
92±3
43±5
54±5
240±20
All values are expressed as a percentage±1 SEM of normal pre-
dicted, according to ZAPLETAL et al. [22]. *: effect of trebutaline on
forced expiratory volume in one second (FEV1) and FEV1/
forced vital capacity (FVC), expressed as % change. TGV: tho-
racic gas volume; TLC: total lung capacity; RV: residual volume;
PEF: peak expiratory flow; MEF25: maximal mid-expiratory
flow at 25% of FVC; MMEF25–75: maximal midexpiratory flow;
Raw: airway resistance.
95±3
85±4
118±3
106±3
140±7
92±3
41±5
54±5
234±17
96±3
86±4
+6±1
+2±1
120±3
107±3
142±8
91±2
44±6
53±5
239±20
97±3
86±4
+6±1
+3±1
121±4
107±2
145±7
90±2
42±5
55±5
246±20
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Side-effects
Five patients complained of dizziness as a result of the
use of the flutter. This improved after they were instructed
not to breathe too quickly or too forcefully through the
flutter.
Discussion
This study compared two physiotherapy aids, the flutter
and the PEP mask, in children with CF. There was no sig-
nificant change in lung function after one session or after
2 weeks of twice-daily physiotherapy with the flutter or
the PEP mask. Oxygenation and symptoms were similar
during treatment with both methods.
It needs to be explained that sputum production, a logi-
cal outcome variable for expectoration studies [15, 28],
was not taken into account because, in our and others'
experience, it appears that children will swallow most
sputum and mixing with saliva will occur [7, 12, 29]. Sev-
eral studies have tried to measure lung function changes
as a result of expectoration methods, some with negative
results [5, 19] and some with significant changes even
after a single session [11]. Widely varying methodologies
in patients with varying severity of lung disease could
well explain the different outcomes. Regarding the PEP
mask, several studies failed to show an improvement in
forced expiratory flows or lung volumes after several weeks
of daily treatment [5, 20]. In contrast, others showed a sig-
nificant improvement in lung volumes and expiratory
flows after 15 days of PEP mask physiotherapy by  CF pa-
tients hospitalized for a pulmonary exacerbation [21]. It is
unclear, however, whether improvements in the latter study
were the result of physiotherapy or of another aspect of
treatment. A preliminary report described a significant
im-provement in Raw after one session of physiotherapy
with the PEP mask [17]. Some authors have used "high-
pressure PEP" [11, 21], by combining forced expiration
and the PEP mask. It may not be appropriate to compare
the present results, obtained with low-pressure PEP, with
those of high-pressure PEP, although there is no evidence
that high and low PEP have different effects.
In agreement with two other studies [30, 31], no signif-
icant change in lung function was seen after one session
of physiotherapy with the flutter. Other authors, however,
have reported a significant improvement in lung function
after one session with the flutter and an effect of the flutter
on end-expiratory flows [17, 18]. However, as these pati-
ents were hospitalized and received antibiotics, valid esti-
mation of the separate effect of physiotherapy seems
impossible. Improvement in lung function (VC, FEV1 and
PEF) after 14 days of physiotherapy with the flutter was
demonstrated in elderly patients with chronic obstructive
pulmonary disease [16].
As a result of physiotherapy lung volumes may increase
and a reduction in unequal ventilation may lead to an
improvement in gas exchange and, hence, oxygenation.
However, in agreement with others [31, 32], we found no
significant changes in oxygenation with the use of the
PEP mask or the flutter. This could be due to the relatively
high baseline values of our patients; indeed, a significant
improvement in saturation during use of the PEP mask
was documented in a group of CF patients with much
lower baseline values [33]. However, six subjects had
short-lasting desaturations after the flutter and this was
seen in only one patient after PEP. It may be speculated
that such short desaturations reflect a transient mismatch
of ventilation and perfusion, owing to the mobilization of
sputum from peripheral airways, and the data suggest that
this happens more often with the flutter.
As a group, the patients did not prefer one of the two
devices. However, some younger patients apparently had
difficulty in using the flutter correctly. This differs from
experience reported in other studies that physiotherapy
with the flutter can be performed by young children from
the age of 3 yrs [28]. The patients in the present study had
performed physiotherapy with the use of the PEP mask
for an average of 4.0 yrs prior to the study, while the flut-
ter was a new device for them. This may have influenced
the results but this seems unlikely, as good compliance
was observed with both techniques.
In conclusion, the effects of two physiotherapy tech-
niques, the positive expiratory pressure mask and the flut-
ter, on symptoms and lung function were compared in
children with cystic fibrosis. No differences were found
between the techniques. Long-term studies may reveal
effects that are not apparent after 2 weeks. For the time
being, it seems best to choose the method that matches the
patient's abilities and preference in order to improve com-
pliance with the physiotherapy regimen.
Acknowledgements: The authors are grateful to
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